Pediatric tuberculosis in Alberta first nations (1991-2000): Outbreaks and the protective effect of bacille Calmette-Guérin (BCG) vaccine

Canadian Journal of Public Health

Volumn 95, Issue 4, 2004, Pages 249-255

  Long, Richard ^a   Whittaker, Denise ^b   Russell, Krista ^c   Kuninomoto, Dennis ^a   Reid, Robert ^d   Fanning, Anne ^a   Nobert, Ewa ^a   Melenka, Lyle ^a   Yacoub, Wadieh ^c   Bhargava, Ravi ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Alberta Health and Wellness   (Canada)

^c HEALTH CANADA   (Canada)

^d CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ADULT; CANADA; CHILD; CONTROLLED STUDY; DNA FINGERPRINTING; EPIDEMIC; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYCOBACTERIUM TUBERCULOSIS; POPULATION DISTRIBUTION; POPULATION RESEARCH; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUBERCULIN TEST; TUBERCULOMA; TUBERCULOSIS;

EID: 4344702891     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405124     Document Type: Review

References (66)

1. Long R, Sutherland K, Kunimoto D, Cowie R, Manfreda J. The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: Identification of high risk groups. Int J Tuber Lung Dis 2002;6:615-21.
2. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analysis of the published literature. Pediatrics 1995;96:29-35.
3. Fine PEM. BCG vaccines and vaccination. In: Reichman LB, Hershfield ES (Eds.), Tuberculosis: A Comprehensive International Approach, 2nd Edition. Lung Biology in Health and Disease, vol 144. New York, NY: Marcel Dekker, Inc, 2000;503-22.
4. Scheifele D, Law B, Jadavji T on behalf of IMPACT. Disseminated bacille Calmette-Guerin infection: three recent Canadian cases. CCDR 1998;24-9:1-5.
5. Cunningham JA, Kellner JD, Bridge PJ, Trevenen CL, McLeod DR, Davies HD. Disseminated bacille Calmette-Guerin infection in an infant with a novel deletion in the interferon gamma receptor gene. Int J Tuberc Lung Dis 2000;4:791-94.
6. International Union Against Tuberculosis and Lung Disease. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guérin (BCG) in countries with a low prevalence of tuberculosis. Tuberc Lung Dis 1994;75:179-81.
7. Houston S, Fanning A, Soskolne CL, Fraser N. The effectiveness of bacillus Calmette-Guerin (BCG) vaccination against tuberculosis. Am J Epidemiol 1990;131:340-48.
8. Menzies D, Pourier L. Diagnosis of tuberculosis infection and disease. In: Long R (Ed.), The Canadian Tuberculosis Standards, 5th edition. Ottawa: Health Canada and the Canadian Lung Association, 2000;45-65.
9. Leung AN, Muller NL, Pineda PR, FitzGerald JM. Primary tuberculosis in childhood: Radiologic manifestations. Radiology 1992;182:87-91.
10. Tannenbaum TN, Fanning A. Contact follow-up and outbreak management in tuberculosis control. In: Long R (Ed.), The Canadian Tuberculosis Standards, 5th edition. Ottawa: Health Canada and the Canadian Lung Association, 2000;175-86
11. Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D. The relative versus absolute noncontagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol 2003;24:831-38.
12. Falk A, O'Connor JB, Pratt PC, Webb WR, Wier JA, Wolinsky E. Classification of pulmonary tuberculosis. In: Diagnostic Standards and Classification of Tuberculosis, 12th edition. National Tuberculosis and Respiratory Disease Association, New York, 1969;68.
13. Ferguson RG, Simes AB. BCG vaccination of infants in Saskatchewan. Tubercle 1949;30:5-11.
14. Young TK, Hershfield ES. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians. Am J Public Health 1986;76:783-86.
15. Fayers PM, Barnett GD. The risk of tuberculous infection in Saskatchewan. Bull Int Union Tuberc Lung Dis 1975;50:62-69.
16. Young TK, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuberc Lung Dis 1992;73:94-100.
17. Comstock G. Frost revisited: The modern epidemiology of tuberculosis. Am J Epidemiol 1975;101:363-82.
18. Sutherland I. The epidemiology of tuberculosis - is prevention better than cure. Bull Int Union Tuberc 1981;56:127-34.
19. Sutherland I, Lindgren I. The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle 1979;60:225-31.
20. Sterne JAC, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998;2:200-7.
21. Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle 1976;57:17-43.
22. Porth FJ. Tuberculosis control among Indians in Saskatchewan. Can J Public Health 1968;59:111-14.
23. FitzGerald JM, Fanning A, Hoeppner V, Hershfield E, Kunimoto D, and the Canadian Molecular Epidemiology of TB Study Group. The molecular epidemiology of tuberculosis in western Canada. Int J Tuberc Lung Dis 2003;7:132-38.
24. Sharma MK, Al-Azem A, Wolfe J, Hershfield E, Kabani A. Identification of a predominant isolate of Mycobacterium tuberculosis using molecular epidemiology tools and in vitro cytokine responses. BMC Infect Dis. http://www.biomedcentral.com/1471-2334/3/3.
25. FitzGerald JM. A preliminary report of three cluster outbreaks of tuberculosis in British Columbia. Can Commun Dis Rep 1994;20-1:1-3.
26. FitzGerald JM, Black WA, Kunimoto D. Evaluation of non-HIV-related, drug-sensitive cluster outbreaks of tuberculosis with PCR-based DNA fingerprinting. Can Respir J 1996;3:317-21.
27. Grzybowski S, Allen EA. The challenge of tuberculosis in decline. Am Rev Respir Dis 1964;90:707-20.
28. Starke JR. Modern approach to the diagnosis and treatment of tuberculosis in children. Pediatr Clin North Am 1988;35:441-64.
29. Lincoln EM. Epidemics of tuberculosis. Adv Tuberc Res 1965;14:157-201.
30. Raffalli J, Sepkowitz KA, Armstrong D. Community based outbreaks of tuberculosis. Arch Intern Med 1996; 156:1053-60.
31. Curtis AB, Ridzon R, Vogel R, McDonough S, Hargraves S, Ferry J, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999;341:1491-95.
32. . Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954;69:724-32.
33. Gryzbowski S, Barnett GD, Styblo K. Contacts of cases of active pulmonary tuberculosis. Report #3 of TSRU. Bull Int Union Tuberc 1975;50:90-106.
34. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 1976;57:275-99.
35. Rose CE Jr, Zerbe GO, Lantz SO, Bailey WC. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis 1979; 119:603-9.
36. Sultan L, Nyka W, Mills C, O'Grady F, Wells W, Riley R. Tuberculosis disseminators: A study of the variable aerial infectivity of tuberculosis patients. Am Rev Respir Dis 1960;82:358-69.
37. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: A general review. Adv Tuberc Res 1970;17:28-106.
38. Miller FJW, Seale RME, Taylor MD. Tuberculosis in Children. Boston, MA: Little Brown, 1963.
39. Heimbeck J. Incidence of tuberculosis in young adult women, with special reference to employment Br J Tubercle 1938;32:154-66.
40. Badger TL, Ayvasian LF. Tuberculosis in nurses: Clinical observations on its pathogenesis as seen in a fifteen year follow-up of 745 nurses. Am Rev Tuberc 1949;60:305-31.
41. Daniels M. Primary tuberculosis infection in nurses: Manifestations and prognosis. Lancet 1944;244:165-70.
42. Karns JR. Tuberculin sensitivity and tuberculosis in nursing and medical students. Dis Chest 1961;40:291-301.
43. Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. Height, weight, tuberculous infection and tuberculous disease. Arch Environ Health 1971;22:106-12.
44. Comstock GW, Palmer CE. Long term results of BCG vaccination in the southern United States. Am Rev Respir Dis 1966;93:171-83.
45. Greenwood CMT, Fujiwara TM, Boothroid LJ, Miller MA, Frappier D, Fanning EA, et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. Am J Hum Genet 2000;67:405-16.
46. Mah MW, Fanning EA. An epidemic of primary tuberculosis in a Canadian Aboriginal community. Can J Infect Dis 1991;2:133-41.
47. Davies JW. Epidemics of tuberculosis in Canada in the sixties. CMAJ 1976;96:1156-60.
48. Rideout VK, Hiltz JE. An epidemic of tuberculosis in a rural high school in 1967. Can J Public Health 1969;60:22-28.
49. Arneil AS, Battershill J. A mini-epidemic of tuberculosis in the Upper Fraser Valley Health Unit. Can J Public Health 1973;64:497-99.
50. Enarson DA, Gryzbowski S. Incidence of active tuberculosis in the native population of Canada. CMAJ 1986; 134:1149-52.
51. Clark M, Riben P, Nowgesic E. The association of housing density, isolation and tuberculosis in Canadian First Nations communities. Int J Epidemiol 2002;31:940-45.
52. Gaudette LA, Ellis E. Tuberculosis in Canada: A focal disease requiring distinct control strategies for different groups. Tuberc Lung Dis 1993;74:244-53.
53. Lifschitz M. The value of the tuberculin skin test as a screening tool for tuberculosis among BCG-vaccinated children. Pediatrics 1965;36:624-27.
54. Karalliede S, Katugha LP, Uragoda CG. The tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987;68:33-38
55. Menzies R, Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:190-98.
56. Sepulveda R, Burr C, Ferrer X, Sorensen R. Booster effect of tuberculin testing in healthy 6 year-old children vaccinated with bacillus Calmette-Guérin at birth in Santiago, Chile. Pediatr Infect Dis J 1988;7:578-81.
57. Sepulveda R, Ferrer X, Latrach C, Sorensen R. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990;142:24-28.
58. Menzies RI, Vissandjee B, Rocher I, St. Germain Y. The booster effect in 2-step tuberculin testing among adults in Montreal. Ann Intern Med 1994;120:190-98.
59. Friedland IR. The booster effect with repeat tuberculin testing in children and its relationship to BCG vaccination. S Afr Med J 1990;77:387-89.
60. Wilson JM, Galbraith JD, Grzybowski S. Tuberculosis in Eskimo children. A comparison in children vaccinated with bacille Calmette-Guérin and non-vaccinated children. Am Rev Respir Dis 1973;108:559-64.
61. Shannon A, Kelly P, Lucey M, Cooney M, Corcoran P, Clancy L. Isoniazid resistant tuberculosis in a school outbreak: The protective effect of BCG. Eur Respir J 199 1;4:778-82.
62. McMurray DN, Carlomagno MA, Mintzer CL, Tetzlaff CL. Mycobacterium bovis BCG vaccine fails to protect protein deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis. Infect Immun 1985;50:555-59.
63. McMurray DN, Mintzer CL, Tetzlaff CL, Carlomagno MA. Influence of dietary protein on the protective effect of BCG in guinea pigs. Tubercle 1986;67:31-39.
64. Galbraith JD, Grzybowski S, Law CL, Rowe J. Tuberculosis in Indian children. CMAJ 1969;11:497-502.
65. Young TK. BCG vaccination among Canadian Indians and Inuit: The epidemiologic basis for policy decision. Can J Public Health 1985;76:124-29.
66. Bleicker MA, Grzybowski S, Styblo K, Sutherland I. Possibilities of omitting BCG vaccination on a random basis in countries where BCG is obligatory at birth. Bull IUAT 1970;44:61-62.